Universitätsklinikum Schleswig-Holstein (UKSH)

Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma (2021) Straka C, Salwender H, Knop S, Vogel M, Muller J, Metzner B, Langer C, et al. Journal article TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer (2021) Stuerken C, Moebus V, Milde-Langosch K, Schmatloch S, Fasching P, Rueschoff J, Stickeler E, et al. Journal article Re-Irradiation in head & neck cancer - a pooled analysis of 253 individual cases (2021) Roesch J, Oertel M, Fabian A, Hoeck M, Von Der Gruen J, Loeser A, Suess C, et al. Conference contribution Patient-oriented Comparison of Systems Therapies for advanced Melanoma: a multicenter Cross-Sectional Study (2021) Thiem A, Mashhadiakbar P, Cussigh C, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, et al. Conference contribution Labour Induction with Misoprostol in German Obstetric Clinics: What Are the Facts on Such Use? (2021) Kehl S, Weiss C, Rath W, Schneider M, Stumpfe F, Faschingbauer F, Beckmann M, Stelzl P Journal article, Review article Empfehlungen für die strukturellen Voraussetzungen der perinatologischen Versorgung in Deutschland (Entwicklungsstufe S2k, AWMF-Leitlinien-Register Nr087-001, März 2021) (2021) Rossi R, Bauer NH, Becke-Jakob K, Grab D, Herting E, Mitschdoerfer B, Olbertz DM, et al. Journal article, Review article Management of Intrahepatic Cholestasis of Pregnancy: Recommendations of the Working Group on Obstetrics and Prenatal Medicine - Section on Maternal Disorders (2021) Hagenbeck C, Hamza A, Kehl S, Maul H, Lammert F, Keitel V, Hutten MC, Pecks U Journal article Induction of LabourGuideline of the DGGG, OEGGG and SGGG (S2k, AWMF Registry No. 015-088, December 2020) (2021) Kehl S, Hösli I, Pecks U, Reif P, Schild RL, Schmidt M, Schmitz D, et al. Journal article Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease (2021) Audain E, Wilsdon A, Breckpot J, Izarzugaza JM, Fitzgerald TW, Kahlert AK, Sifrim A, et al. Journal article Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas (2021) Liebers N, Duell J, Fitzgerald D, Kerkhoff A, Noerenberg D, Kaebisch E, Acker F, et al. Journal article